These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 17266558)

  • 1. Alteration of the proline at position 7 of the HIV-1 spacer peptide p1 suppresses viral infectivity in a strain dependent manner.
    Hill MK; Bellamy-McIntyre A; Vella LJ; Campbell SM; Marshall JA; Tachedjian G; Mak J
    Curr HIV Res; 2007 Jan; 5(1):69-78. PubMed ID: 17266558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proline residues within spacer peptide p1 are important for human immunodeficiency virus type 1 infectivity, protein processing, and genomic RNA dimer stability.
    Hill MK; Shehu-Xhilaga M; Crowe SM; Mak J
    J Virol; 2002 Nov; 76(22):11245-53. PubMed ID: 12388684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proline residues in human immunodeficiency virus type 1 p6(Gag) exert a cell type-dependent effect on viral replication and virion incorporation of Pol proteins.
    Dettenhofer M; Yu XF
    J Virol; 1999 Jun; 73(6):4696-704. PubMed ID: 10233929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the C terminus Gag protein in human immunodeficiency virus type 1 virion assembly and maturation.
    Yu XF; Matsuda Z; Yu QC; Lee TH; Essex M
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():3171-9. PubMed ID: 8847526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncoupling human immunodeficiency virus type 1 Gag and Pol reading frames: role of the transframe protein p6* in viral replication.
    Leiherer A; Ludwig C; Wagner R
    J Virol; 2009 Jul; 83(14):7210-20. PubMed ID: 19403679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of the Gag-Pol transframe domain p6* and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1.
    Paulus C; Ludwig C; Wagner R
    Virology; 2004 Dec; 330(1):271-83. PubMed ID: 15527852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.
    Fitzon T; Leschonsky B; Bieler K; Paulus C; Schröder J; Wolf H; Wagner R
    Virology; 2000 Mar; 268(2):294-307. PubMed ID: 10704338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of the hydrophobic tail of the human immunodeficiency virus type 1 p6(Gag) protein produces a mutant that fails to package its envelope protein.
    Ott DE; Chertova EN; Busch LK; Coren LV; Gagliardi TD; Johnson DG
    J Virol; 1999 Jan; 73(1):19-28. PubMed ID: 9847302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in human immunodeficiency virus type 1 Gag at positions L449 and P453 are linked to I50V protease mutants in vivo and cause reduction of sensitivity to amprenavir and improved viral fitness in vitro.
    Maguire MF; Guinea R; Griffin P; Macmanus S; Elston RC; Wolfram J; Richards N; Hanlon MH; Porter DJ; Wrin T; Parkin N; Tisdale M; Furfine E; Petropoulos C; Snowden BW; Kleim JP
    J Virol; 2002 Aug; 76(15):7398-406. PubMed ID: 12097552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner.
    Demirov DG; Orenstein JM; Freed EO
    J Virol; 2002 Jan; 76(1):105-17. PubMed ID: 11739676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein.
    Peters S; Muñoz M; Yerly S; Sanchez-Merino V; Lopez-Galindez C; Perrin L; Larder B; Cmarko D; Fakan S; Meylan P; Telenti A
    J Virol; 2001 Oct; 75(20):9644-53. PubMed ID: 11559796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
    Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
    Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of host cell MAPK/ERK-2 incorporation into lentivirus particles: characterization of the interaction between MAPK/ERK-2 and proline-rich-domain containing capsid region of structural protein Gag.
    Gupta P; Singhal PK; Rajendrakumar P; Padwad Y; Tendulkar AV; Kalyanaraman VS; Schmidt RE; Srinivasan A; Mahalingam S
    J Mol Biol; 2011 Jul; 410(4):681-97. PubMed ID: 21762808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 protease with leucine zipper fused at N-terminus exhibits enhanced linker amino acid-dependent activity.
    Yu FH; Wang CT
    Retrovirology; 2018 Apr; 15(1):32. PubMed ID: 29655366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of the C-terminal gag cleavage sites in human immunodeficiency virus type 1.
    Coren LV; Thomas JA; Chertova E; Sowder RC; Gagliardi TD; Gorelick RJ; Ott DE
    J Virol; 2007 Sep; 81(18):10047-54. PubMed ID: 17634233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.
    Sei S; Yang QE; O'Neill D; Yoshimura K; Nagashima K; Mitsuya H
    J Virol; 2000 May; 74(10):4621-33. PubMed ID: 10775598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of human immunodeficiency virus type 1 variants with an insertion mutation in the p6(gag) and p6(pol) genes under highly active antiretroviral therapy.
    Ibe S; Shibata N; Utsumi M; Kaneda T
    Microbiol Immunol; 2003; 47(1):71-9. PubMed ID: 12636256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The central region of human immunodeficiency virus type 1 p6 protein (Gag residues S14-I31) is dispensable for the virus in vitro.
    Bleiber G; Peters S; Martinez R; Cmarko D; Meylan P; Telenti A
    J Gen Virol; 2004 Apr; 85(Pt 4):921-927. PubMed ID: 15039534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of nucleocapsid of HIV-1 in virus assembly.
    Dawson L; Yu XF
    Virology; 1998 Nov; 251(1):141-57. PubMed ID: 9813210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitination of HIV-1 and MuLV Gag.
    Ott DE; Coren LV; Chertova EN; Gagliardi TD; Schubert U
    Virology; 2000 Dec; 278(1):111-21. PubMed ID: 11112487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.